KLC
APYX icon

Kent Lake Capital’s Apyx Medical APYX Stock Holding History

Kent Lake Capital’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,049,273
Closed -$4.71M – 39
2022
Q3 		$4.71M Sell
1,049,273
-150,727
-13% -$1.08M 3.09% 15
2022
Q2 		$7.03M Buy
1,200,000
+1,065,006
+789% +$5.46M 3.87% 10
2022
Q1 		$882K Buy
+134,994
New +$1.33M 0.55% 35

Other funds holding APYX

ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAC
Cowen and Company New York $2.9B AUM 105.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return